These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|||||||
| For the quarterly period ended: |
|
|||||||
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||
| For the transition period from __________ to __________ | |||||
|
|
||
| (Exact name of registrant as specified in its charter) | ||
|
(State or other jurisdiction of incorporation or organization)
|
||
|
(Address of principal executive offices)
|
||
|
(IRS Employer Identification No.)
|
||
|
(Zip Code)
|
||
| (Registrant’s telephone number, including area code) | ||
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
|
|
|
The New York Stock Exchange (
|
||||||
|
|
☒
|
Accelerated filer
|
☐
|
|||||||||||
|
Non-accelerated filer
|
☐
|
Smaller reporting company
|
|
|||||||||||
|
Emerging growth company
|
|
|||||||||||||
| Page No. | ||||||||
|
C
onsolidated statements of comprehensive income/(loss) –
three and nine
months ended
September 30, 2025
and
2024
|
||||||||
|
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| Net revenues | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Cost of goods sold |
|
|
|
|
|||||||||||||||||||
| Gross profit/(loss) |
(
|
|
|
|
|||||||||||||||||||
| Selling, general, and administrative expenses |
|
|
|
|
|||||||||||||||||||
| Technical and research expenses |
|
|
|
|
|||||||||||||||||||
| Restructuring expenses, net |
|
|
|
|
|||||||||||||||||||
| Operating income/(loss) |
(
|
|
(
|
|
|||||||||||||||||||
| Interest expense/(income), net |
|
|
|
|
|||||||||||||||||||
| Other expense/(income), net |
(
|
|
|
|
|||||||||||||||||||
| Income (loss) before income taxes |
(
|
|
(
|
|
|||||||||||||||||||
| Income tax expense/(benefit) |
(
|
|
(
|
|
|||||||||||||||||||
| Net income/(loss) |
(
|
|
(
|
|
|||||||||||||||||||
| Net income/(loss) attributable to the noncontrolling interest |
|
|
|
|
|||||||||||||||||||
| Net income/(loss) attributable to the Company | $ |
(
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||
| Earnings per share attributable to Company shareholders - Basic | $ |
(
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||
| Earnings per share attributable to Company shareholders - Diluted | $ |
(
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||
| Shares of the Company used in computing earnings per share: | |||||||||||||||||||||||
| Basic |
|
|
|
|
|||||||||||||||||||
| Diluted |
|
|
|
|
|||||||||||||||||||
| Dividends declared per Class A share | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
|
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| Net income/(loss) | $ |
(
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||
| Other comprehensive income/(loss), before tax: | |||||||||||||||||||||||
| Foreign currency translation and other adjustments |
|
|
|
(
|
|||||||||||||||||||
| Pension settlement/curtailment |
|
|
(
|
|
|||||||||||||||||||
| Amortization of pension liability adjustments: | |||||||||||||||||||||||
| Prior service credit |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Net actuarial loss |
|
|
|
|
|||||||||||||||||||
| Payments and amortization related to interest rate swaps included in earnings |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Derivative valuation adjustment |
|
(
|
(
|
|
|||||||||||||||||||
| Income taxes related to items of other comprehensive income/(loss): | |||||||||||||||||||||||
| Pension settlement/curtailment |
|
|
|
|
|||||||||||||||||||
| Amortization of prior service credit |
|
|
|
|
|||||||||||||||||||
| Amortization of net actuarial loss |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Payments and amortization related to interest rate swaps included in earnings |
|
|
|
|
|||||||||||||||||||
| Derivative valuation adjustment |
(
|
|
|
(
|
|||||||||||||||||||
| Comprehensive income/(loss) |
(
|
|
(
|
|
|||||||||||||||||||
| Comprehensive income/(loss) attributable to the noncontrolling interest |
|
(
|
|
(
|
|||||||||||||||||||
| Comprehensive income/(loss) attributable to the Company | $ |
(
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||
| (unaudited) | |||||||||||
| September 30, 2025 | December 31, 2024 | ||||||||||
| Assets | |||||||||||
| Cash and cash equivalents | $ |
|
$ |
|
|||||||
| Accounts receivable, net |
|
|
|||||||||
| Contract assets, net |
|
|
|||||||||
| Inventories |
|
|
|||||||||
| Income taxes prepaid and receivable |
|
|
|||||||||
| Prepaid expenses and other current assets |
|
|
|||||||||
| Total current assets |
|
|
|||||||||
| Property, plant and equipment, net |
|
|
|||||||||
| Intangibles, net |
|
|
|||||||||
| Goodwill |
|
|
|||||||||
| Deferred income taxes |
|
|
|||||||||
| Other assets |
|
|
|||||||||
| Total assets | $ |
|
$ |
|
|||||||
| Liabilities and Shareholders' Equity | |||||||||||
| Accounts payable | $ |
|
$ |
|
|||||||
| Accrued liabilities |
|
|
|||||||||
| Income taxes payable |
|
|
|||||||||
| Total current liabilities |
|
|
|||||||||
| Long-term debt |
|
|
|||||||||
| Other noncurrent liabilities |
|
|
|||||||||
| Deferred taxes and other liabilities |
|
|
|||||||||
| Total liabilities |
|
|
|||||||||
| Commitments and Contingencies (Note 17) |
|
|
|||||||||
| Shareholders' Equity: | |||||||||||
|
Preferred stock, par value $
|
|
|
|||||||||
|
Class A Common Stock, par value $
|
|
|
|||||||||
| Additional paid in capital |
|
|
|||||||||
| Retained earnings |
|
|
|||||||||
| Accumulated items of other comprehensive income: | |||||||||||
| Translation adjustments |
(
|
(
|
|||||||||
| Pension and postretirement liability adjustments |
(
|
(
|
|||||||||
| Derivative valuation adjustment |
(
|
(
|
|||||||||
|
Treasury stock (Class A), at cost;
|
(
|
(
|
|||||||||
| Total shareholders' equity |
|
|
|||||||||
| Noncontrolling interest |
|
|
|||||||||
| Total equity |
|
|
|||||||||
| Total liabilities and shareholders' equity | $ |
|
$ |
|
|||||||
|
Nine Months Ended
September 30, |
|||||||||||||||||||||||
| 2025 | 2024 | ||||||||||||||||||||||
| Cash flows from operating activities: | |||||||||||||||||||||||
| Net income/(loss) | $ |
(
|
$ |
|
|||||||||||||||||||
| Adjustments to reconcile net income/(loss) to net cash provided by operating activities: | |||||||||||||||||||||||
| Depreciation |
|
|
|||||||||||||||||||||
| Amortization |
|
|
|||||||||||||||||||||
| Change in deferred taxes and other liabilities |
(
|
(
|
|||||||||||||||||||||
| Impairment of property, plant and equipment |
(
|
|
|||||||||||||||||||||
| Non-cash interest expense |
|
|
|||||||||||||||||||||
| Contract loss provision |
|
|
|||||||||||||||||||||
| Compensation and benefits paid or payable in Class A Common Stock |
|
|
|||||||||||||||||||||
| Provision/(recovery) for credit losses from uncollected receivables and contract assets |
|
|
|||||||||||||||||||||
| Foreign currency remeasurement loss/(gain) on intercompany loans |
|
|
|||||||||||||||||||||
| Fair value adjustment on foreign currency contracts |
|
|
|||||||||||||||||||||
| Gain on sale of assets |
(
|
(
|
|||||||||||||||||||||
| Changes in operating assets and liabilities that provided/(used) cash: | |||||||||||||||||||||||
| Accounts receivable |
|
|
|||||||||||||||||||||
| Contract assets |
(
|
(
|
|||||||||||||||||||||
| Inventories |
(
|
|
|||||||||||||||||||||
| Prepaid expenses and other current assets |
(
|
|
|||||||||||||||||||||
| Income taxes prepaid and receivable |
(
|
|
|||||||||||||||||||||
| Accounts payable |
|
|
|||||||||||||||||||||
| Accrued liabilities |
(
|
(
|
|||||||||||||||||||||
| Income taxes payable |
(
|
(
|
|||||||||||||||||||||
| Other noncurrent liabilities |
(
|
(
|
|||||||||||||||||||||
| Other, net |
(
|
(
|
|||||||||||||||||||||
| Net cash provided by operating activities |
|
|
|||||||||||||||||||||
| Cash flows from investing activities: | |||||||||||||||||||||||
| Purchases of property, plant and equipment |
(
|
(
|
|||||||||||||||||||||
| Purchased software |
(
|
(
|
|||||||||||||||||||||
| Proceeds received from sale of assets |
|
|
|||||||||||||||||||||
| Net cash used in investing activities |
(
|
(
|
|||||||||||||||||||||
| Cash flows from financing activities: | |||||||||||||||||||||||
| Proceeds from borrowings |
|
|
|||||||||||||||||||||
| Repayment of borrowings |
(
|
(
|
|||||||||||||||||||||
| Purchase of Treasury shares |
(
|
|
|||||||||||||||||||||
| Taxes paid in lieu of share issuance |
(
|
(
|
|||||||||||||||||||||
| Dividends paid |
(
|
(
|
|||||||||||||||||||||
| Net cash used in financing activities |
(
|
(
|
|||||||||||||||||||||
| Effect of exchange rate changes on cash and cash equivalents |
|
(
|
|||||||||||||||||||||
| Decrease in cash and cash equivalents |
(
|
(
|
|||||||||||||||||||||
| Cash and cash equivalents at beginning of period |
|
|
|||||||||||||||||||||
| Cash and cash equivalents at end of period | $ |
|
$ |
|
|||||||||||||||||||
| Three Months Ended September 30, 2025 | ||||||||||||||||||||||||||
| (in thousands) | MC | AEC | Corporate | Total | ||||||||||||||||||||||
| Net revenues | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Cost of goods sold |
|
|
|
|
||||||||||||||||||||||
| Gross profit |
|
(
|
|
(
|
||||||||||||||||||||||
| Selling, general and administrative expenses |
|
|
|
|
||||||||||||||||||||||
| Technical and research expenses |
|
|
|
|
||||||||||||||||||||||
| Restructuring expenses, net |
|
|
|
|
||||||||||||||||||||||
| Operating income/(loss) | $ |
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||
| Three Months Ended September 30, 2024 | ||||||||||||||||||||||||||
| (in thousands) | MC | AEC | Corporate | Total | ||||||||||||||||||||||
| Net revenues | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Cost of goods sold |
|
|
|
|
||||||||||||||||||||||
| Gross profit |
|
|
|
|
||||||||||||||||||||||
| Selling, general and administrative expenses |
|
|
|
|
||||||||||||||||||||||
| Technical and research expenses |
|
|
|
|
||||||||||||||||||||||
| Restructuring expenses, net |
|
|
|
|
||||||||||||||||||||||
| Operating income/(loss) | $ |
|
$ |
(
|
$ |
(
|
$ |
|
||||||||||||||||||
| Nine Months Ended September 30, 2025 | ||||||||||||||||||||||||||
| (in thousands) | MC | AEC | Corporate | Total | ||||||||||||||||||||||
| Net revenues | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Cost of goods sold |
|
|
|
|
||||||||||||||||||||||
| Gross profit |
|
(
|
|
|
||||||||||||||||||||||
| Selling, general and administrative expenses |
|
|
|
|
||||||||||||||||||||||
| Technical and research expenses |
|
|
|
|
||||||||||||||||||||||
| Restructuring expenses, net |
|
|
|
|
||||||||||||||||||||||
| Operating income/(loss) | $ |
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||
| Nine Months Ended September 30, 2024 | ||||||||||||||||||||||||||
| (in thousands) | MC | AEC | Corporate | Total | ||||||||||||||||||||||
| Net revenues | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Cost of goods sold |
|
|
|
|
||||||||||||||||||||||
| Gross profit |
|
|
|
|
||||||||||||||||||||||
| Selling, general and administrative expenses |
|
|
|
|
||||||||||||||||||||||
| Technical and research expenses |
|
|
|
|
||||||||||||||||||||||
| Restructuring expenses, net |
|
|
|
|
||||||||||||||||||||||
| Operating income/(loss) | $ |
|
$ |
(
|
$ |
(
|
$ |
|
||||||||||||||||||
| Three months ended September 30, | Nine months ended September 30, | |||||||||||||
|
(in thousands)
|
2025 | 2024 | 2025 | 2024 | ||||||||||
| Depreciation and amortization | ||||||||||||||
| Machine Clothing | $ |
|
$ |
|
$ |
|
$ |
|
||||||
| Albany Engineered Composites |
|
|
|
|
||||||||||
| Corporate |
|
|
|
|
||||||||||
| Consolidated depreciation and amortization | $ |
|
$ |
|
$ |
|
$ |
|
||||||
| Three months ended September 30, | Nine months ended September 30, | |||||||||||||
|
(in thousands)
|
2025 | 2024 | 2025 | 2024 | ||||||||||
| Operating income/(loss) | ||||||||||||||
| Machine Clothing | $ |
|
$ |
|
$ |
|
$ |
|
||||||
| Albany Engineered Composites |
(
|
(
|
(
|
(
|
||||||||||
| Corporate |
(
|
(
|
(
|
(
|
||||||||||
| Consolidated Operating income/(loss) | $ |
(
|
$ |
|
$ |
(
|
$ |
|
||||||
|
Reconciling items:
|
||||||||||||||
| Interest income/(loss) |
(
|
(
|
(
|
(
|
||||||||||
|
Interest expense
|
|
|
|
|
||||||||||
| Other (income)/expense, net |
(
|
|
|
|
||||||||||
| Income/(loss) before income taxes | $ |
(
|
$ |
|
$ |
(
|
$ |
|
||||||
|
(in thousands)
|
September 30, 2025 | December 31, 2024 | ||||||
| Segment assets | ||||||||
| Machine Clothing | $ |
|
$ |
|
||||
| Albany Engineered Composites |
|
|
||||||
| Reconciling items: | ||||||||
| Cash |
|
|
||||||
| Income taxes prepaid and receivable, and Deferred income taxes |
|
|
||||||
| Prepaid expenses and other current assets, and Other assets |
|
|
||||||
| Consolidated total assets | $ |
|
$ |
|
||||
| Nine months ended September 30, | ||||||||
|
(in thousands)
|
2025 | 2024 | ||||||
| Capital expenditures and purchased software | ||||||||
| Machine Clothing | $ |
|
$ |
|
||||
| Albany Engineered Composites |
|
|
||||||
| Total capital expenditures and purchased software | $ |
|
$ |
|
||||
| Three months ended September 30, 2025 | |||||||||||
|
(in thousands)
|
Point in Time Revenue
Recognition
|
Over Time Revenue
Recognition
|
Total
|
||||||||
| Machine Clothing | $ |
|
$ |
|
$ |
|
|||||
| Albany Engineered Composites: | |||||||||||
| ASC |
|
|
|
||||||||
| Other AEC |
|
|
|
||||||||
|
Total Albany Engineered Composites
|
$ |
|
$ |
|
$ |
|
|||||
| Total revenues | $ |
|
$ |
|
$ |
|
|||||
| Three months ended September 30, 2024 | |||||||||||
|
(in thousands)
|
Point in Time Revenue
Recognition
|
Over Time Revenue
Recognition
|
Total
|
||||||||
| Machine Clothing | $ |
|
$ |
|
$ |
|
|||||
| Albany Engineered Composites: | |||||||||||
| ASC |
|
|
|
||||||||
| Other AEC |
|
|
|
||||||||
|
Total Albany Engineered Composites
|
$ |
|
$ |
|
$ |
|
|||||
| Total revenues | $ |
|
$ |
|
$ |
|
|||||
| Nine months ended September 30, 2025 | |||||||||||
|
(in thousands)
|
Point in Time Revenue
Recognition |
Over Time Revenue
Recognition |
Total | ||||||||
| Machine Clothing | $ |
|
$ |
|
$ |
|
|||||
| Albany Engineered Composites: | |||||||||||
| ASC |
|
|
|
||||||||
| Other AEC |
|
|
|
||||||||
| Total Albany Engineered Composites | $ |
|
$ |
|
$ |
|
|||||
| Total revenues | $ |
|
$ |
|
$ |
|
|||||
| Nine months ended September 30, 2024 | |||||||||||
| (in thousands) |
Point in Time Revenue
Recognition |
Over Time Revenue
Recognition |
Total | ||||||||
| Machine Clothing | $ |
|
$ |
|
$ |
|
|||||
| Albany Engineered Composites: | |||||||||||
| ASC |
|
|
|
||||||||
| Other AEC |
|
|
|
||||||||
| Total Albany Engineered Composites | $ |
|
$ |
|
$ |
|
|||||
| Total revenues | $ |
|
$ |
|
$ |
|
|||||
| Three months ended September 30, | Nine months ended September 30, | |||||||||||||
|
(in thousands)
|
2025 | 2024 | 2025 | 2024 | ||||||||||
| Americas PMC | $ |
|
$ |
|
$ |
|
$ |
|
||||||
|
Eurasia PMC
|
|
|
|
|
||||||||||
| Engineered Fabrics |
|
|
|
|
||||||||||
| Total Machine Clothing Net revenues | $ |
|
$ |
|
$ |
|
$ |
|
||||||
|
Pension plans
|
Other postretirement benefits
|
|||||||||||||
|
(in thousands)
|
2025 | 2024 | 2025 | 2024 | ||||||||||
| Components of net periodic benefit cost/(income): | ||||||||||||||
|
Service cost
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||
| Interest cost |
|
|
|
|
||||||||||
|
Expected return on assets
|
(
|
(
|
|
|
||||||||||
|
Curtailment cost/(income)
|
(
|
|
|
|
||||||||||
|
Settlement cost/(income)
|
|
|
|
|
||||||||||
| Amortization of prior service cost/(income) |
(
|
(
|
(
|
(
|
||||||||||
|
Amortization of net actuarial loss
|
|
|
(
|
(
|
||||||||||
|
Net periodic benefit cost/(credit)
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||
|
Three months ended September 30,
|
Nine months ended September 30, | |||||||||||||
| (in thousands) | 2025 | 2024 | 2025 | 2024 | ||||||||||
| Machine Clothing | $ |
|
$ |
|
$ |
|
$ |
|
||||||
| Albany Engineered Composites |
|
|
|
|
||||||||||
| Corporate expenses |
|
|
|
|
||||||||||
| Total | $ |
|
$ |
|
$ |
|
$ |
|
||||||
| Nine months ended September 30, 2025 |
Total
restructuring costs incurred |
Termination
and other costs |
Impairment of assets | Pension Curtailment (Gain)/Loss | ||||||||||
| (in thousands) | ||||||||||||||
| Machine Clothing | $ |
|
$ |
|
$ |
|
$ |
(
|
||||||
| Albany Engineered Composites |
|
|
|
|
||||||||||
| Corporate expenses |
|
|
|
|
||||||||||
| Total | $ |
|
$ |
|
$ |
|
$ |
(
|
||||||
| Nine months ended September 30, 2024 |
Total
restructuring costs incurred |
Termination
and other costs |
Impairment of assets |
Pension Curtailment (Gain)/Loss
|
||||||||||
| (in thousands) | ||||||||||||||
| Machine Clothing | $ |
|
$ |
|
$ |
|
$ |
|
||||||
| Albany Engineered Composites |
|
|
|
|
||||||||||
| Corporate expenses |
|
|
|
|
||||||||||
| Total | $ |
|
$ |
|
$ |
|
$ |
|
||||||
| (in thousands) | December 31, 2024 |
Restructuring
charges accrued |
Payments and other | September 30, 2025 | ||||||||||
| Total restructuring and other liabilities | $ |
|
$ |
|
$ |
(
|
$ |
|
||||||
| (in thousands) | December 31, 2023 |
Restructuring
charges accrued |
Payments and other | September 30, 2024 | ||||||||||
| Total restructuring and other liabilities | $ |
|
$ |
|
$ |
(
|
$ |
|
||||||
| Three months ended September 30, | Nine months ended September 30, | |||||||||||||
|
(in thousands)
|
2025 | 2024 | 2025 | 2024 | ||||||||||
|
Currency transaction losses/(gains)
|
$ |
(
|
$ |
|
$ |
|
$ |
|
||||||
| Derivative instruments losses/(gains) |
(
|
(
|
(
|
|
||||||||||
| Components of net periodic pension and postretirement cost other than service cost |
|
|
|
|
||||||||||
| Other losses/(gains) |
(
|
|
(
|
(
|
||||||||||
| Total other (income)/expense, net | $ |
(
|
$ |
|
$ |
|
$ |
|
||||||
| Three months ended September 30, | Nine months ended September 30, | |||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||
| Effective income tax rate |
|
% |
|
% |
|
% |
|
% | ||||||
| Three months ended September 30, | Nine months ended September 30, | |||||||||||||
| (in thousands, except earnings per share) | 2025 | 2024 | 2025 | 2024 | ||||||||||
| Net income/(loss) attributable to the Company | $ |
(
|
$ |
|
$ |
(
|
$ |
|
||||||
| Weighted average number of shares: | ||||||||||||||
| Weighted average number of shares used in calculating basic net income/(loss) per share |
|
|
|
|
||||||||||
| Effect of dilutive stock-based compensation plans: | ||||||||||||||
| Restricted stock units and multi-year awards |
|
|
|
|
||||||||||
| Weighted average number of shares used in calculating diluted net income/(loss) per share |
|
|
|
|
||||||||||
|
(in thousands)
|
Translation
adjustments
|
Pension and
postretirement
liability
adjustments
|
Derivative
valuation
adjustment
|
Total Accumulated Other
Comprehensive Income/(Loss) |
||||||||||
| December 31, 2024 | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||
|
Foreign currency translation and other adjustments
|
|
(
|
(
|
|
||||||||||
|
Pension settlement/curtailment, net of tax
|
— |
(
|
— |
(
|
||||||||||
| Interest (expense)/income related to swaps reclassified to the Consolidated Statements of Income/(Loss), net of tax | — | — |
(
|
(
|
||||||||||
| Pension and postretirement liability adjustments reclassified to Consolidated Statements of Income/(Loss), net of tax | — |
|
— |
|
||||||||||
| Net current period other comprehensive income/(loss) |
|
(
|
(
|
|
||||||||||
| September 30, 2025 | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||
| (in thousands) |
Translation
adjustments
|
Pension and
postretirement
liability
adjustments
|
Derivative
valuation
adjustment
|
Total Accumulated Other
Comprehensive Income/(Loss) |
||||||||||
| December 31, 2023 | $ |
(
|
$ |
(
|
$ |
|
$ |
(
|
||||||
|
Foreign currency translation and other adjustments
|
(
|
(
|
|
(
|
||||||||||
| Interest (expense)/income related to swaps reclassified to the Consolidated Statements of Income/(Loss), net of tax | — | — |
(
|
(
|
||||||||||
| Pension and postretirement liability adjustments reclassified to Consolidated Statements of Income/(Loss), net of tax | — |
|
— |
|
||||||||||
| Net current period other comprehensive income/(loss) |
(
|
|
(
|
(
|
||||||||||
| September 30, 2024 | $ |
(
|
$ |
(
|
$ |
|
$ |
(
|
||||||
| Three months ended September 30, | Nine months ended September 30, | |||||||||||||
|
(in thousands)
|
2025 | 2024 | 2025 | 2024 | ||||||||||
| Pre-tax Derivative valuation reclassified from Accumulated Other Comprehensive Income/(Loss): | ||||||||||||||
| Interest (income)/expense, net related to interest rate swaps included in Income/(loss) before taxes | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||
| Income tax effect |
|
|
|
|
||||||||||
| Effect on net income due to items reclassified from Accumulated Other Comprehensive Income/(Loss) | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||
|
Pre-tax pension and postretirement liabilities reclassified from Accumulated Other Comprehensive Income:
|
||||||||||||||
|
Pension settlement/curtailment
|
$ |
|
$ |
|
$ |
(
|
$ |
|
||||||
| Amortization of prior service credit | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||
|
Amortization of net actuarial loss
|
|
|
|
|
||||||||||
| Total pre-tax amount reclassified |
|
|
(
|
|
||||||||||
| Income tax effect |
(
|
(
|
|
(
|
||||||||||
| Effect on net income due to items reclassified from Accumulated Other Comprehensive Income | $ |
|
$ |
|
$ |
(
|
$ |
|
||||||
| ASC Noncontrolling Interest | Nine months ended September 30, | |||||||
| (in thousands, except percentages) | 2025 | 2024 | ||||||
| Net income of Albany Safran Composites (ASC) | $ |
|
$ |
|
||||
| Less: Return attributable to the Company's preferred holding |
|
|
||||||
| Net income of ASC available for common ownership | $ |
|
$ |
|
||||
| Ownership percentage of noncontrolling shareholder |
|
% |
|
% | ||||
| Net income attributable to the noncontrolling interest | $ |
|
$ |
|
||||
| Noncontrolling interest, beginning of year | $ |
|
$ |
|
||||
| Net income attributable to noncontrolling interest |
|
|
||||||
| Changes in other comprehensive income attributable to the noncontrolling interest |
|
(
|
||||||
|
ASC Noncontrolling interest, end of interim period
|
$ |
|
$ |
|
||||
|
Arcari Noncontrolling interest, end of interim period
|
$ |
|
$ |
|
||||
| Total Noncontrolling interest, end of interim period | $ |
|
$ |
|
||||
| (in thousands) | September 30, 2025 | December 31, 2024 | ||||||
| Trade and other accounts receivable | $ |
|
$ |
|
||||
| Bank promissory notes |
|
|
||||||
| Allowance for expected credit losses |
(
|
(
|
||||||
| Accounts receivable, net | $ |
|
$ |
|
||||
| (in thousands) | September 30, 2025 | December 31, 2024 | ||||||
| Contract assets | $ |
|
$ |
|
||||
|
Allowance for expected credit losses
|
(
|
(
|
||||||
| Contract assets, net | $ |
|
$ |
|
||||
| Contract liabilities | $ |
|
$ |
|
||||
| (in thousands) | September 30, 2025 | December 31, 2024 | ||||||
| Raw materials | $ |
|
$ |
|
||||
|
Work in process
|
|
|
||||||
| Finished goods |
|
|
||||||
|
Total inventories
|
$ |
|
$ |
|
||||
| September 30, 2025 | ||||||||||||||
| (in thousands) |
Amortization
life in years |
Gross carrying amount | Accumulated amortization and other | Net carrying amount | ||||||||||
| Finite-lived assets: | ||||||||||||||
| AEC Trademarks and trade names |
|
$ |
|
$ |
(
|
$ |
|
|||||||
| AEC Technology |
|
|
(
|
|
||||||||||
| AEC Intellectual property |
|
|
(
|
|
||||||||||
| AEC Customer relationships |
|
|
(
|
|
||||||||||
| Heimbach Developed technology |
|
|
(
|
|
||||||||||
| Total Finite-lived intangible assets | $ |
|
$ |
(
|
$ |
|
||||||||
| Indefinite-lived intangible assets: | ||||||||||||||
| Heimbach Trade name | $ |
|
$ | — | $ |
|
||||||||
| MC Goodwill |
|
— |
|
|||||||||||
| AEC Goodwill |
|
— |
|
|||||||||||
| Total Indefinite-lived intangible assets: | $ |
|
$ | — | $ |
|
||||||||
| December 31, 2024 | ||||||||||||||
| (in thousands) |
Amortization
life in years |
Gross carrying amount | Accumulated amortization and other | Net carrying amount | ||||||||||
| Finite-lived assets: | ||||||||||||||
| AEC Trademarks and trade names |
|
$ |
|
$ |
(
|
$ |
|
|||||||
| AEC Technology |
|
|
(
|
|
||||||||||
| AEC Intellectual property |
|
|
(
|
|
||||||||||
| AEC Customer relationships |
|
|
(
|
|
||||||||||
| Heimbach Developed technology |
|
|
(
|
|
||||||||||
| Total Finite-lived assets | $ |
|
$ |
(
|
$ |
|
||||||||
| Indefinite-lived intangible assets: | ||||||||||||||
| Heimbach Trade name | $ |
|
$ | — | $ |
|
||||||||
| MC Goodwill |
|
— |
|
|||||||||||
| AEC Goodwill |
|
— |
|
|||||||||||
| Total Indefinite-lived intangible assets: | $ |
|
$ | — | $ |
|
||||||||
| (in thousands) | December 31, 2024 |
Other
Changes |
Amortization |
Currency
Translation |
September 30, 2025 | ||||||||||||
| Finite-lived intangible assets: | |||||||||||||||||
| AEC Trademarks and trade names | $ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
|||||||
| AEC Technology |
|
|
(
|
|
|
||||||||||||
| AEC Intellectual property |
|
|
(
|
|
|
||||||||||||
| AEC Customer relationships |
|
|
(
|
|
|
||||||||||||
| Heimbach Developed technology |
|
(
|
(
|
|
|
||||||||||||
| Total Finite-lived intangible assets | $ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
|||||||
| Indefinite-lived intangible assets: | |||||||||||||||||
| Heimbach Trade name | $ |
|
$ |
|
$ | — | $ |
|
$ |
|
|||||||
| MC Goodwill |
|
|
— |
|
|
||||||||||||
| AEC Goodwill |
|
|
— |
|
|
||||||||||||
| Total Indefinite-lived assets: | $ |
|
$ |
|
$ | — | $ |
|
$ |
|
|||||||
| (in thousands, except interest rates) | September 30, 2025 | December 31, 2024 | |||||||||
| Borrowings under the Amended Credit Agreement | |||||||||||
| USD borrowings | $ |
|
$ |
|
|||||||
| EUR borrowings |
|
|
|||||||||
| Foreign bank debt |
|
|
|||||||||
| Total bank debt |
|
|
|||||||||
| Less: Current maturities of long-term debt |
|
|
|||||||||
| Long-term debt | $ |
|
$ |
|
|||||||
| Leverage Ratio | Commitment Fee | ABR Spread |
Term Benchmark/ Daily
Simple SOFR Spread |
||||||||
|
<
|
|
|
|
||||||||
|
≥
|
|
|
|
||||||||
|
≥
|
|
|
|
||||||||
|
≥
|
|
|
|
||||||||
| September 30, 2025 | December 31, 2024 | ||||||||||||||||||||||
|
Quoted
prices in
active
markets
|
Significant
other
observable
inputs
|
Quoted
prices in
active
markets
|
Significant
other
observable
inputs
|
||||||||||||||||||||
|
(in thousands)
|
(Level 1)
|
(Level 2)
|
(Level 1)
|
(Level 2)
|
|||||||||||||||||||
| Fair Value | |||||||||||||||||||||||
|
Assets:
|
|||||||||||||||||||||||
| Cash equivalents | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
|
Foreign currency option contracts
|
|
|
|
|
|||||||||||||||||||
|
Foreign currency forward contracts
|
|
|
|
|
|||||||||||||||||||
|
Other Assets:
|
|||||||||||||||||||||||
| Common stock of unaffiliated foreign public company (a) |
|
|
|
|
|||||||||||||||||||
| Interest rate swaps |
|
|
|
|
|||||||||||||||||||
| Liabilities: | |||||||||||||||||||||||
| Other Non-Current Liabilities | |||||||||||||||||||||||
| Foreign currency forward contracts |
|
|
|
|
|||||||||||||||||||
| Interest rate swaps |
|
(
|
|
(
|
|||||||||||||||||||
| Three months ended September 30, | Nine months ended September 30, | |||||||||||||
| (in thousands) | 2025 | 2024 | 2025 | 2024 | ||||||||||
| Derivatives not designated as hedging instruments: | ||||||||||||||
| Foreign currency options (gains)/losses | $ |
(
|
$ |
(
|
$ |
(
|
$ |
|
||||||
| (in thousands, except number of claims) |
Opening
Number of
Claims
|
Claims
Dismissed,
Settled, or
Resolved
|
New Claims |
Closing
Number of
Claims
|
Amounts Paid to
Settle or Resolve |
||||||||||||
| For the period ended December 31, 2024 |
|
|
|
|
$ |
|
|||||||||||
| For the period ended September 30, 2025 |
|
|
|
|
$ |
|
|||||||||||
|
Class A
Common Stock
|
Additional paid-in capital
|
Retained
earnings
|
Accumulated items of other comprehensive income
|
Class A
Treasury Stock
|
Noncontrolling Interest
|
Total Shareholders' Equity | |||||||||||||||||||||||||||||
|
Shares
|
Amount
|
Shares
|
Amount
|
||||||||||||||||||||||||||||||||
| June 30, 2025 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|
$ |
(
|
$ |
|
$ |
|
|||||||||||||||||||
| Net income/(loss) | — | — | — |
(
|
— | — | — |
|
(
|
||||||||||||||||||||||||||
| Stock issued under incentive compensation plans |
|
— | — | — | — | — | — | — | — | ||||||||||||||||||||||||||
| Taxes paid in lieu of share issuance | — | — |
(
|
— | — | — | — | — |
(
|
||||||||||||||||||||||||||
| Stock-based compensation | — | — |
|
|
|||||||||||||||||||||||||||||||
| Purchase of Treasury shares (a) | — | — | — | — | — |
|
(
|
— |
(
|
||||||||||||||||||||||||||
|
Dividends declared on Class A Common Stock, $
|
— | — | — |
(
|
— | — | — | — |
(
|
||||||||||||||||||||||||||
| Cumulative translation adjustments | — | — | — | — |
|
— | — |
|
|
||||||||||||||||||||||||||
| Pension and postretirement liability adjustments | — | — | — | — |
|
— | — | — |
|
||||||||||||||||||||||||||
| Derivative valuation adjustment and other | — | — | — | — |
|
— | — | — |
|
||||||||||||||||||||||||||
| September 30, 2025 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|
$ |
(
|
$ |
|
$ |
|
|||||||||||||||||||
|
Class A
Common Stock |
Additional paid-in capital |
Retained
earnings |
Accumulated items of other comprehensive income |
Class A
Treasury Stock |
Noncontrolling Interest | Total Shareholders' Equity | |||||||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | ||||||||||||||||||||||||||||||||
| December 31, 2024 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|
$ |
(
|
$ |
|
$ |
|
|||||||||||||||||||
| Net income/(loss) | — | — | — |
(
|
— | — | — |
|
(
|
||||||||||||||||||||||||||
| Stock issued under incentive compensation plans |
|
— |
(
|
— | — | — | — | — |
(
|
||||||||||||||||||||||||||
| Taxes paid in lieu of share issuance | — | — |
(
|
— | — | — | — | — |
(
|
||||||||||||||||||||||||||
| Stock-based compensation | — | — |
|
— | — | — | — | — |
|
||||||||||||||||||||||||||
| Shares issued to Directors' |
|
— |
|
— | — | — | — | — |
|
||||||||||||||||||||||||||
| Purchase of Treasury shares (a) | — | — | — | — | — |
|
(
|
— |
(
|
||||||||||||||||||||||||||
|
Dividends declared on Class A Common Stock, $
|
— | — | — |
(
|
— | — | — | — |
(
|
||||||||||||||||||||||||||
| Dividends paid to noncontrolling interests | — | — | — | — | — | — | — |
(
|
(
|
||||||||||||||||||||||||||
| Cumulative translation adjustments | — | — | — | — |
|
— | — |
|
|
||||||||||||||||||||||||||
| Pension and postretirement liability adjustments | — | — | — | — |
(
|
— | — | — |
(
|
||||||||||||||||||||||||||
| Derivative valuation adjustment and other | — | — | — |
(
|
(
|
— | — |
|
(
|
||||||||||||||||||||||||||
| September 30, 2025 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|
$ |
(
|
$ |
|
$ |
|
|||||||||||||||||||
|
Class A
Common Stock
|
Additional paid-in capital
|
Retained
earnings
|
Accumulated items of other comprehensive income |
Class A
Treasury Stock
|
Noncontrolling Interest
|
Total
Shareholders' Equity |
|||||||||||||||||||||||||||||
|
(in thousands)
|
Shares
|
Amount
|
Shares
|
Amount
|
|||||||||||||||||||||||||||||||
| June 30, 2024 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|
$ |
(
|
$ |
|
$ |
|
|||||||||||||||||||
| Net income/(loss) | — | — | — |
|
— | — | — |
|
|
||||||||||||||||||||||||||
| Compensation and benefits paid or payable in shares |
|
— |
|
— | — | — | — | — |
|
||||||||||||||||||||||||||
|
Dividends declared on Class A Common Stock, $
|
— | — | — |
(
|
— | — | — | — |
(
|
||||||||||||||||||||||||||
| Initial equity related to Noncontrolling interest in Arcari | — | — | — | — | — | — | — |
(
|
(
|
||||||||||||||||||||||||||
| Cumulative translation adjustments | — | — | — | — |
|
— | — |
(
|
|
||||||||||||||||||||||||||
| Pension and postretirement liability adjustments | — | — | — | — |
(
|
— | — | — |
(
|
||||||||||||||||||||||||||
| Derivative valuation adjustment | — | — | — | — |
(
|
— | — | — |
(
|
||||||||||||||||||||||||||
| September 30, 2024 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|
$ |
(
|
$ |
|
$ |
|
|||||||||||||||||||
|
Class A
Common Stock
|
Additional paid-in capital
|
Retained
earnings
|
Accumulated items of other comprehensive income |
Class A
Treasury Stock
|
Noncontrolling Interest
|
Total
Shareholders' Equity |
|||||||||||||||||||||||||||||
|
(in thousands)
|
Shares
|
Amount
|
Shares
|
Amount
|
|||||||||||||||||||||||||||||||
| December 31, 2023 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|
$ |
(
|
$ |
|
$ |
|
|||||||||||||||||||
| Net income/(loss) | — | — | — |
|
— | — | — |
|
|
||||||||||||||||||||||||||
| Compensation and benefits paid or payable in shares |
|
— |
|
— | — | — | — | — |
|
||||||||||||||||||||||||||
| Shares issued to Directors' |
|
— |
|
0 | — | — | — | — |
|
||||||||||||||||||||||||||
|
Class A Common Stock, $
|
— | — | — |
(
|
— | — | — | — |
(
|
||||||||||||||||||||||||||
| Inital equity related to Noncontolling interest in Arcari | — | — | — | 0 | — | — | — |
(
|
(
|
||||||||||||||||||||||||||
| Cumulative translation adjustments | — | — | — | — |
(
|
— | — |
(
|
(
|
||||||||||||||||||||||||||
| Pension and postretirement liability adjustments | — | — | — | 0 |
|
— | — | — |
|
||||||||||||||||||||||||||
| Derivative valuation adjustment | — | — | — | — |
(
|
— | — | — |
(
|
||||||||||||||||||||||||||
| September 30, 2024 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|
$ |
(
|
$ |
|
$ |
|
|||||||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||
| (in thousands, except percentages) | 2025 | 2024 | % Change | 2025 | 2024 | % Change | ||||||||||||||
| Net revenues | $ | 261,434 | $ | 298,386 | (12.4) | % | $ | 861,607 | $ | 943,710 | (8.7) | % | ||||||||
| Gross profit/(loss) | (49,938) | 90,384 | (155.3) | % | 144,055 | 311,453 | (53.7) | % | ||||||||||||
| Gross profit/(loss) margin | (19.1) | % | 30.3 | % | 16.7 | % | 33.0 | % | ||||||||||||
| Operating expenses: | ||||||||||||||||||||
| Selling, general and administrative expenses | 51,905 | 52,097 | (0.4) | % | 164,219 | 162,447 | 1.1 | % | ||||||||||||
| Technical and research expenses | 11,467 | 10,844 | 5.7 | % | 35,915 | 35,369 | 1.5 | % | ||||||||||||
| Restructuring expenses, net | 3,197 | 2,272 | 40.7 | % | 9,895 | 6,584 | 50.3 | % | ||||||||||||
| Total operating expenses | 66,569 | 65,213 | 2.1 | % | 210,029 | 204,400 | 2.8 | % | ||||||||||||
| Total operating expenses as a percentage of net revenues | 25.5 | % | 21.9 | % | 361 bp | 24.4 | % | 21.7 | % | 272 bp | ||||||||||
| Operating income/(loss) | (116,507) | 25,171 | (562.9) | % | (65,974) | 107,053 | (161.6) | % | ||||||||||||
| Interest expense, net | 5,897 | 2,411 | 144.6 | % | 14,702 | 8,680 | 69.4 | % | ||||||||||||
| Other (income)/expense, net | (347) | 3,257 | (110.7) | % | 4,170 | 5,932 | (29.7) | % | ||||||||||||
| Income/(loss) before income taxes | (122,057) | 19,503 | (725.8) | % | (84,846) | 92,441 | (191.8) | % | ||||||||||||
| Income tax expense/(benefit) | (24,419) | 1,282 | (2004.8) | % | (13,889) | 22,131 | (162.8) | % | ||||||||||||
| Reported income tax rate | 20.0 | % | 6.6 | % | 1,341 | bp | 16.4 | % | 23.9 | % | (753) | bp | ||||||||
| Net income/(loss) | $ | (97,638) | $ | 18,221 | (635.9) | % | $ | (70,957) | $ | 70,310 | (200.9) | % | ||||||||
| Three months ended September 30, | Nine months ended September 30, | |||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||
| Effective income tax rate | 20.0 | % | 6.6 | % | 16.4 | % | 23.9 | % | ||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||
| (in thousands, except percentages) | 2025 | 2024 | % Change | 2025 | 2024 | % Change | ||||||||||||||
| Segment net revenues | ||||||||||||||||||||
| Machine Clothing | $ | 174,950 | $ | 183,033 | (4.4) | % | $ | 530,573 | $ | 561,828 | (5.6) | % | ||||||||
| Albany Engineered Composites | $ | 86,484 | $ | 115,353 | (25.0) | % | $ | 331,034 | $ | 381,882 | (13.3) | % | ||||||||
| Consolidated total | $ | 261,434 | $ | 298,386 | (12.4) | % | $ | 861,607 | $ | 943,710 | (8.7) | % | ||||||||
| Segment Gross profit | ||||||||||||||||||||
| Machine Clothing | $ | 82,070 | $ | 88,921 | (7.7) | % | $ | 245,731 | $ | 262,449 | (6.4) | % | ||||||||
| Albany Engineered Composites | $ | (132,008) | $ | 1,463 | (9123.1) | % | $ | (101,676) | $ | 49,004 | (307.5) | % | ||||||||
| Consolidated total | $ | (49,938) | $ | 90,384 | (155.3) | % | $ | 144,055 | $ | 311,453 | (53.7) | % | ||||||||
| Segment Gross profit margin | ||||||||||||||||||||
| % of Segment net revenues - MC | 46.9 | % | 48.6 | % | 46.3 | % | 46.7 | % | ||||||||||||
| % of Segment net revenues - AEC | (152.6) | % | 1.3 | % | (30.7) | % | 12.8 | % | ||||||||||||
| % of Consolidated net revenues | (19.1) | % | 30.3 | % | 16.7 | % | 33.0 | % | ||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||
| (in thousands, except percentages) | 2025 | 2024 | % Change | 2025 | 2024 | % Change | ||||||||||||||
| Segment selling, general and administrative expenses | ||||||||||||||||||||
| Machine Clothing | $ | 30,291 | $ | 32,048 | (5.5) | % | $ | 98,841 | $ | 95,384 | 3.6 | % | ||||||||
| % of Segment net revenues | 17.3 | % | 17.5 | % | (20) | bp | 18.6 | % | 17.0 | % | 165 | bp | ||||||||
| Albany Engineered Composites | $ | 12,218 | $ | 11,923 | 2.5 | % | $ | 34,121 | $ | 36,249 | (5.9) | % | ||||||||
| % of Segment net revenues | 14.1 | % | 10.3 | % | 379 | bp | 10.3 | % | 9.5 | % | 82 | bp | ||||||||
| Corporate | $ | 9,396 | $ | 8,126 | 15.6 | % | $ | 31,257 | $ | 30,814 | 1.4 | % | ||||||||
| % of Consolidated net revenues | 3.6 | % | 2.7 | % | 87 | bp | 3.6 | % | 3.3 | % | 36 | bp | ||||||||
| Consolidated total selling, general and administrative expenses | $ | 51,905 | $ | 52,097 | (0.4) | % | $ | 164,219 | $ | 162,447 | 1.1 | % | ||||||||
| Segment technical and research expenses | ||||||||||||||||||||
| Machine Clothing | $ | 6,716 | $ | 7,042 | (4.6) | % | $ | 21,332 | $ | 22,066 | (3.3) | % | ||||||||
| % of Segment net revenues | 3.8 | % | 3.8 | % | (1) | bp | 4.0 | % | 3.9 | % | 9 | bp | ||||||||
| Albany Engineered Composites | $ | 3,673 | $ | 3,802 | (3.4) | % | $ | 11,472 | $ | 13,303 | (13.8) | % | ||||||||
| % of Segment net revenues | 4.2 | % | 3.3 | % | 95 | bp | 3.5 | % | 3.5 | % | (2) | bp | ||||||||
| Corporate | $ | 1,078 | $ | 0 | — | % | $ | 3,111 | $ | 0 | — | % | ||||||||
| % of Consolidated net revenues | 0.4 | % | — | % | 41 | bp | 0.4 | % | — | % | 36 | bp | ||||||||
| Consolidated total technical and research expenses | $ | 11,467 | $ | 10,844 | 5.7 | % | $ | 35,915 | $ | 35,369 | 1.5 | % | ||||||||
| Segment restructuring expenses, net | ||||||||||||||||||||
| Machine Clothing | $ | 1,960 | $ | 2,207 | (11.2) | % | $ | 6,322 | $ | 3,294 | 91.9 | % | ||||||||
| % of Segment net revenues | 1.1 | % | 1.2 | % | (9) | bp | 1.2 | % | 0.6 | % | 61 | bp | ||||||||
| Albany Engineered Composites | $ | 113 | $ | 34 | 232.4 | % | $ | 1,801 | $ | 3,144 | (42.7) | % | ||||||||
| % of Segment net revenues | 0.1 | % | — | % | 10 | bp | 0.5 | % | 0.8 | % | (28) | bp | ||||||||
| Corporate | $ | 1,124 | $ | 31 | 3525.8 | % | $ | 1,772 | $ | 146 | 1113.7 | % | ||||||||
| % of Consolidated net revenues | 0.4 | % | — | % | 42 | bp | 0.2 | % | — | % | 19 | bp | ||||||||
| Consolidated total restructuring expenses, net | $ | 3,197 | $ | 2,272 | 40.7 | % | $ | 9,895 | $ | 6,584 | 50.3 | % | ||||||||
| Segment Operating income/(loss) | ||||||||||||||||||||
| Machine Clothing | $ | 43,103 | $ | 47,624 | (9.5) | % | $ | 119,236 | $ | 141,705 | (15.9) | % | ||||||||
| Albany Engineered Composites | $ | (148,012) | $ | (14,296) | 935.3 | % | $ | (149,070) | $ | (3,692) | 3937.6 | % | ||||||||
| Corporate expenses | $ | (11,598) | $ | (8,157) | 42.2 | % | $ | (36,140) | $ | (30,960) | 16.7 | % | ||||||||
| Segment Operating income | $ | (116,507) | $ | 25,171 | (562.9) | % | $ | (65,974) | $ | 107,053 | (161.6) | % | ||||||||
| Nine months ended September 30, | ||||||||
|
(in thousands)
|
2025 | 2024 | ||||||
| Net income/(loss) | $ | (70,957) | $ | 70,310 | ||||
| Depreciation and amortization | 65,480 | 67,003 | ||||||
| Changes in working capital (a) | (15,108) | 7,700 | ||||||
| Changes in other noncurrent liabilities and deferred taxes | (26,171) | (7,569) | ||||||
| Other operating items | 125,528 | 2,541 | ||||||
| Net cash provided by operating activities | 78,772 | 139,985 | ||||||
| Net cash used in investing activities | (45,566) | (61,053) | ||||||
|
Net cash used in financing activities
|
(48,268) | (121,773) | ||||||
| Effect of exchange rate changes on cash and cash equivalents | 8,089 | (3,357) | ||||||
|
Decrease in cash and cash equivalents
|
(6,973) | (46,198) | ||||||
| Cash and cash equivalents at beginning of year | 115,283 | 173,420 | ||||||
|
Cash and cash equivalents at end of period
|
$ | 108,310 | $ | 127,222 | ||||
| (in thousands, except interest rates) | |||||
| Long-term debt: | |||||
| Credit agreement borrowings outstanding (due in 2028): | |||||
| USD borrowings (end of period all-in interest rate of 6.0%) | 250,000 | ||||
| EUR borrowings (end of period all-in interest rate of 3.5%) | 52,815 | ||||
| Foreign bank debt | 0 | ||||
| Total | $ | 302,815 | |||
| Period | Total number of shares purchased | Average price paid per share | Total number of shares purchased as part of publicly announced program | Approx. dollar value of shares that may yet be purchased under the program (in thousands) | ||||||||||
| July 1 to July 31, 2025 | — | — | — | 143,445 | ||||||||||
| August 1 to August 31, 2025 | 809,911 | 61.74 | 809,911 | 93,445 | ||||||||||
| September 1 to September 30, 2025 | — | — | — | 93,445 | ||||||||||
| Total | 809,911 | 61.74 | 809,911 | $ | 93,445 | |||||||||
| Exhibit No. | Description | ||||
| 31.1 | |||||
| 31.2 | |||||
| 32.1 | |||||
| 101.INS | XBRL Instance Document- the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | ||||
| 101.SCH | XBRL Taxonomy Extension Schema Document. | ||||
| 101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document. | ||||
| 101.DEF | XBRL Taxonomy Extension Definition Linkbase Document. | ||||
| 101.LAB | XBRL Taxonomy Extension Label Linkbase Document. | ||||
| 101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document. | ||||
| 104 | Cover page formatted as Inline XBRL and contained in Exhibit 101 | ||||
| ALBANY INTERNATIONAL CORP. | ||||||||
| (Registrant) | ||||||||
| Date: November 6, 2025 | By | /s/ Willard C. Station | ||||||
|
Willard C. Station
Executive Vice President, Chief Financial Officer (Principal Financial Officer) |
||||||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|